ArticleClinical rheumatology2026

Real-world outcomes after anifrolumab initiation in systemic lupus erythematosus: a pragmatic treat-to-target analysis.

Dalifer Freites Núñez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.